Healthcare -
Biotechnology - NASDAQ - US
$ 13.93
-1.12 %
$ 1.46 B
Market Cap
-9.17
P/E
EWTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities EWTX - Edgewise Therapeutics, Inc.
249 M
LAST VALUE
38.66%
2 YEAR CAGR
58.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR